Evidence map›Paper›PMID 24763117›Full record

ReviewNutrients2014

Ascorbic acid and the brain: rationale for the use against cognitive decline.

Fiona E Harrison, Gene L Bowman, Maria Cristina Polidori

Abstract readReview
In one paragraph

Review in Nutrients, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. On the physiological and cellular homeostasis of ascorbate.Cellular & molecular biology letters · 2020
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fiona E HarrisonDivision of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. fiona.harrison@vanderbilt.edu.
Gene L BowmanBrain Institute, Department of Neurology, NIA-Aging and Alzheimer's Disease Center Oregon Health and Science University, Portland, OR 97239, USA. bowmang@ohsu.edu.
Maria Cristina PolidoriGeriatrics Department, University of Cologne Medical Faculty, Cologne 50937, Germany. maria.polidori-nelles@uk-koeln.de.

Funding

Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI QUINN, JOSEPH F · 1990 to 2019
$27.7M
NIH Director's Pioneer Award (RMI)DP1OD000392 · OD · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2005 to 2009
$3.3M
Omega 3 Pufas for the Vascular Component of Age-Related Cognitive DeclineR01AG043398 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BOWMAN, GENE LOGAN, SHINTO, LYNNE H · 2013 to 2019
$3.0M
Vitamin C and cognition in Alzheimer's diseaseR01AG038739 · NIA · VANDERBILT UNIVERSITY · PI HARRISON, FIONA EDITH · 2011 to 2014
$1.1M
A platform for individualized nutritional therapy in Alzheimer's diseaseK23AT004777 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI BOWMAN, GENE LOGAN · 2008 to 2012
$639k
NCCIH NIH HHS AT004777NCCIH NIH HHS K23 AT004777NIA NIH HHS AG038739NIA NIH HHS AG043398NIA NIH HHS P30 AG008017NIA NIH HHS R01 AG038739NIA NIH HHS R01 AG043398NIH HHS DP1 OD000392
6 · The paper itself

Abstract

This review is focused upon the role of ascorbic acid (AA, vitamin C) in the promotion of healthy brain aging. Particular attention is attributed to the biochemistry and neuronal metabolism interface, transport across tissues, animal models that are useful for this area of research, and the human studies that implicate AA in the continuum between normal cognitive aging and age-related cognitive decline up to Alzheimer's disease. Vascular risk factors and comorbidity relationships with cognitive decline and AA are discussed to facilitate strategies for advancing AA research in the area of brain health and neurodegeneration.

Indexed as

AgingAlzheimer DiseaseAnimalsAscorbic AcidBrainCognitionCognition DisordersDisease Models, AnimalHumansObservational Studies as TopicRandomized Controlled Trials as TopicRisk FactorsAscorbic Acid

Identifiers

PMID24763117
PMCPMC4011065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.